In recent decades the inappropriate use of antibiotics in farm animals, either as growth enhancers or for treatment of infectious diseases, has resulted both in higher concentrations of antibiotic residues in meat destined for the human food chain and in an increasing prevalence of antibiotic-resistant bacteria (Carlet et al., 2012) . Increased public concerns regarding their potential impact on human health may result in a reduction or cessation in the use of antibiotics in farm animals (Veterinary Record, 2011 . Thus, alternative treatments for the control of infectious diseases in farm animals need to be identified as a research priority. In achieving this goal, the physiological relevance of an animal model to the intended target population becomes a key factor. The majority of models currently used for pharmaceutical research are murine and it is possible that potentially valuable therapeutics are discounted on the basis of lack of responses generated in this system, as shown very recently for sepsis (Seok et al., 2013) . Several non-rodent species, such as cattle, pigs, and chicken, are both valuable models for infectious diseases in humans (Hein and Griebel, 2003; Visscher and Goddard, 2011; Waters et al., 2011; Costa et al., 2012; Meurens et al., 2012) and important clinical targets in their own right. Effective vaccines have been developed for many acute viral and bacterial infections, whereas for others, like tuberculosis (TB), there is still a need for reliable vaccines. Pathology seen in the murine models of TB currently used is very different to the pathology seen in humans (Gupta and Katoch, 2009) , whereas the bovine and human diseases share many similarities (Waters et al., 2011) . For such diseases it is crucial that we use natural disease-models, with the appropriate pathogen models to fill the gaps in our knowledge of disease-pathogenesis, and choosing a research model should be more than just a matter of convenience and convention (Bolker, 2012) .
However, in addition to their potential use as models for human diseases, research in farm-animals models have a "right-ontheir-own," taken the predicted increase in food supply necessary by 70% to support an ever-increasing global population as well as the occurrence of new emerging diseases, such as Schmallenberg virus into account. These challenges can be faced and overcome by an increased readiness of farm animal research centers to apply their models in novel ways, a willingness of the medical profession to accept more suitable diseasemodels, and a willingness of funding agencies and companies to invest in this type of research partnership.
